A panel of clinician scientists with expertise in neuromuscular blockade (NMB) monitoring
was convened with a charge to prepare a consensus statement on indications for and …

Postoperative residual neuromuscular block has been recognized as a potential problem for
decades, and it remains so today. Traditional pharmacologic antagonists …

These practice guidelines provide evidence-based recommendations on the management
of neuromuscular monitoring and antagonism of neuromuscular blocking agents during and …

Background Residual neuromuscular blockade can be avoided with quantitative
neuromuscular monitoring. The authors embarked on a professional practice initiative to …

Unrecognised postoperative residual neuromuscular block remains a frequent occurrence in
recovery rooms. Evidence indicates that current practice continues to perpetuate the status …

BACKGROUND: In patients who receive a nondepolarizing neuromuscular blocking drug
(NMBD) during anesthesia, undetected postoperative residual neuromuscular block is a …

Over the past five decades, quantitative neuromuscular monitoring devices have been used
to examine the incidence of postoperative residual neuromuscular block in international …

New evidence has emerged about the pathophysiological implications of incomplete
neuromuscular recovery. Not only are the pulmonary muscles functionally impaired, but …

Use of peripheral nerve stimulators allows clinicians to administer neuromuscular blocking
and reversal agents in a rational manner. Routine use of quantitative monitors of depth of …

Inappropriate dosing of neostigmine for antagonism of neuromuscular blockade has been
associated with postoperative pulmonary complications. We evaluated the effects of a …